XENE

XENON PHARMACEUTICALS INC

XENE·98420N105·US·Common Stock·Healthcare - Biotechnology-13D/G

XENE (XENON PHARMACEUTICALS INC) is held by 163 institutional investors as of Q2 2026. Largest holders: FMR LLC ($582.4M), BlackRock, Inc. ($454.1M), Avoro Capital Advisors LLC ($348.7M). Net institutional sentiment: Mixed.

163
Holders
(14 Elite)
$4.4B
Total Value
64% (157)
Consensus
100 buying - 57 selling
13F: Insider & Congress: Updated regularly
XENE

Smart Money Verdict

View all
Loading verdict
Held by 163 funds
14 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Aug 31, 2026 · Activists Aug 13, 2026 · Congress none

InsiderKJKENNEY CHRISTOPHER JOHNSell $43KAug 28, 2026
InsiderKJKENNEY CHRISTOPHER JOHNSell $383KAug 28, 2026
ActivistWellington Management Group LLPWellington Management Group LLP1.5%Aug 13, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
9.6M(-10.8%)$582.4M0.0%+54.55%
0
Increased
7.5M(+33.4%)$454.1M0.0%+42.15%
40
Unchanged
5.8M$348.7M3.1%+162.53%
0
Increased
4.6M(+3.8%)$275.9M0.7%+54.62%
45
Decreased
4.4M(-1.6%)$266.7M1.5%+107.76%
0
Increased
2.6M(+36.1%)$157.4M0.0%+32.30%
39
Decreased
2.4M(-11.7%)$142.5M0.0%+112.67%
0
Increased
2M(+14.5%)$118.9M0.0%+51.79%
34
Increased
1.6M(+171.1%)$99.2M0.1%+10.41%
48
Increased
1.5M(+7.5%)$91M0.3%+44.38%
38
Increased
1.6M(+11.3%)$90.8M0.0%+51.82%
33
Increased
1.4M(+12.3%)$86.8M0.0%+38.77%
33
Decreased
1.4M(-70.5%)$86M0.0%+44.02%
0
Decreased
1.4M(-47.2%)$84.6M0.0%+43.05%
0
Increased
1.4M(+25.4%)$82.7M0.0%+53.50%
37
Decreased
1.3M(-3.8%)$77.9M0.1%+41.27%
0
Increased
1.2M(+74.7%)$71.6M0.1%+29.90%
45
Increased
993,126(+297.2%)$59.9M0.0%+11.70%
48
Increased
903,458(+1428.6%)$54.5M0.0%+1.59%
47
Increased
884,319(+30.2%)$53.4M0.0%+53.18%
37

Showing 1-20 of 171

1 / 9
XENEXENEXENON PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used